Results 11 to 20 of about 9,047,322 (291)
Dapagliflozin in Patients With Chronic Kidney Disease
BACKGROUND Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diabetes, is not known.
Bergur V Stefansson +2 more
exaly +2 more sources
Emotional and cognitive changes in chronic kidney disease [PDF]
Chronic kidney disease (CKD) leads to cognitive impairment and emotional changes. However, the precise mechanism underlying the crosstalk between the kidneys and the nervous system is not fully understood.
Duk-Soo Kim +2 more
doaj +1 more source
Kazakhstan CTO Club's recommended guidelines for interventional therapy for coronary chronic total occlusion [PDF]
Chronic total occlusion (CTO) disease refers to obstructive coronary artery disease, which is the degree of direct blood flow of the blood flow TIMI 0 degree of occlusion time 3 months, if there are already well-developed collaterals or bridge ...
Begylan Stambol +3 more
doaj +1 more source
IntroductionFibromyalgia and provoked vestibulodynia are two chronic pain conditions that disproportionately affect women. The mechanisms underlying the pain in these conditions are still poorly understood, but there is speculation that both may be ...
Gabriela Ioachim +9 more
doaj +1 more source
How do our Dialysis Patients Die?
Introduction: Elderly patients are the most frequent patients admitted to dialysis units. Relatively little is known about standards on endof-life (EOL) care among dialysis patients.
Ana Farinha +7 more
doaj +1 more source
Epidemiology of chronic kidney disease: an update 2022.
Chronic kidney disease is a progressive condition that affects >10% of the general population worldwide, amounting to >800 million individuals. Chronic kidney disease is more prevalent in older individuals, women, racial minorities, and in people ...
C. Kovesdy
semanticscholar +1 more source
Can CBC Profile and Liver Function Test Predict Chronic Kidney Disease among a Normal population?
Background: Kidney disorders are mainly diagnosed after a major decline in the renal function. Chronic kidney disease (CKD) is one of the most common disorders of the urinary system defined by gradual reduction of renal function.
Mahmood Moosazadeh +3 more
doaj +1 more source
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
A physiological level of oxygen/nitrogen free radicals and non-radical reactive species (collectively known as ROS/RNS) is termed oxidative eustress or “good stress” and is characterized by low to mild levels of oxidants involved in the regulation of ...
K. Jomová +6 more
semanticscholar +1 more source
Thoracic Lymph Duct Catheterization with a Venous Shunt in the Nonhuman Primate
Background: Biologic therapeutics constitute up to 30% of all drugs approved from 2010 to 2018 and represent a continuous growing market. In contrast to small molecules, biologic therapeutics (>1 kDa MW) are administered parenterally or intravenously due
Jon Ehrmann +5 more
doaj +1 more source
Empagliflozin in Patients with Chronic Kidney Disease
Background This study, the EMPA-KIDNEY trial, was designed to assess the effects of empagliflozin in a broad range of patients with chronic kidney disease (CKD) at risk of progression. Methods We randomly assigned 6609 participants to empagliflozin (10mg
W. Herrington +38 more
semanticscholar +1 more source

